000 01343 a2200373 4500
005 20250515014231.0
264 0 _c20060418
008 200604s 0 0 eng d
022 _a1352-4585
024 7 _a10.1191/135248506ms1249cr
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrohman, E M
245 0 0 _aAzathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms.
_h[electronic resource]
260 _bMultiple sclerosis (Houndmills, Basingstoke, England)
_cFeb 2006
300 _a108-11 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAzathioprine
_xadverse effects
650 0 4 _aFemale
650 0 4 _aGenetic Variation
650 0 4 _aHomozygote
650 0 4 _aHumans
650 0 4 _aImmunosuppressive Agents
_xadverse effects
650 0 4 _aMethyltransferases
_xgenetics
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Sclerosis
_xblood
650 0 4 _aPancytopenia
_xchemically induced
650 0 4 _aPolymorphism, Genetic
700 1 _aHavrdova, E
700 1 _aLevinson, B
700 1 _aSlanar, O
773 0 _tMultiple sclerosis (Houndmills, Basingstoke, England)
_gvol. 12
_gno. 1
_gp. 108-11
856 4 0 _uhttps://doi.org/10.1191/135248506ms1249cr
_zAvailable from publisher's website
999 _c16072965
_d16072965